| 1. |
赖其伦, 章殷希, 丁美萍, 等.Susac综合征临床研究进展[J].中华神经科杂志, 2015, 48(4):347-350.DOI:10.3760/cma.j.issn.1006-7876.2015.04.024..Lai QL, Zhang YX, Ding MP, et al. The clinical research progress of Susac syndrome[J].Chin J Neurol, 2015, 48(4):347-350.DOI:10.3760/cma.j.issn.1006-7876.2015.04.024.
|
| 2. |
White ML, Zhang Y, Smoker WR. Smoker, evolution of lesions in Susac syndrome at serial MR imaging with diffusion-weighted imaging and apparent diffusion coefficient values[J]. AJNR Am J Neuroradiol, 2004, 25(5):706-713.
|
| 3. |
Vodopivec I, Venna N, Rizzo JF 3rd, et al. Clinical features, diagnostic findings, and treatment of Susac syndrome:a case series[J]. J Neurol Sci, 2015, 357(1-2):50-57. DOI:10.1016/j.jns.2015.06.063.
|
| 4. |
Egan RA, Hills WL, Susac JO. Gass plaques and fluorescein leakage in Susac syndrome[J]. J Neurol Sci, 2010, 299(1-2):97-100.DOI:10.1016/j.jns.2010.08.043.
|
| 5. |
Jarius S, Kleffner I, Dörr JM, et al. Clinical, paraclinical and serological findings in Susac syndrome:an international multicenter study[J]. J Neuroinflammation, 2014, 11:46. DOI:10.1186/1742-2094-11-46.
|
| 6. |
Aubart-Cohen F, Klein I, Alexandra JF, et al. Long-term outcome in Susac syndrome[J]. Medicine (Baltimore), 2007, 86(2):93-102.
|
| 7. |
Rennebohm RM, Egan RA, Susac JO. Treatment of Susaćs syndrome[J]. Curr Treat Pttions Neurol, 2008, 10(1):67-74.
|
| 8. |
London F, Pothalil D, Duprez TP, et al. Potential benefits of early aggressive immunotherapy in Susac syndrome[J/OL]. Acta Neurol Belg, 2016[2016-01-19]. http://dx.doi.org/10.1007/s13760-016-0599-0.[published online ahead of print].
|
| 9. |
Galvez-Ruiz A, R Nowilaty S. Unusual presentation of a multiple sclerosis case involving central retinal artery occlusion[J]. Saudi J Ophthalmol, 2015, 29(2):160-164. DOI:10.1016/j.sjopt.2014.12.001.
|
